FEBRILE SEIZURE PANEL

 

Febrile Seizures Panel contains the following tests – SCN1A, SCN1A-DEL/DUP, SCN2A, SCN1B, GABRD, GABRG2

Test Order Code FSP

CPT Codes

83891 x 1, 83892 x 1, 83896 x 26, 83898 x 51, 83900 x 1, 83901 x 24, 83904 x 51, 83909 x 52, 83912 x 1
Indications For Testing For infants and children; Indicators include seizures, including typical febrile seizures or atypical febrile seizures in which seizures occur after six years of age, and afebrile tonic-clonic, myoclonic, absence, or atonic seizures.

Turn Around Time

 Three weeks. Expedited analysis is available upon request for an additional charge.
Specimen Requirements Ship one of the following:

Saliva
You must order either the DNA Specimen Collection Kit – Sponge Swab (Part Number 443006) or the DNA Specimen Collection Kit – Saliva Tube (Part Number 443007) from Transgenomic to send a saliva sample. Follow the directions in the kit for specific saliva collection requirements.

Peripheral Blood
A full 4 ml blood sample in the 4 ml Lavender-top (EDTA) tube provided in the DNA Specimen Collection Kit (Part Number 443002) is required. Keep the sample at ambient temperature and ship by overnight courier to the test laboratory.

Specimen Kits DNA Specimen Collection Kits can be obtained from Transgenomic Labs.
Shipping and Contact Information Transgenomic Labs
Five Science Park, New Haven, CT 06511 USA
Phone:1.877.274.9432 Fax: 203.786.3418
E-mail: labservice@transgenomiclabs.com
Test Submission  and Patient Consent Forms

    Test Requisition and Patient Consent Form

Due to the unique nature of genetic testing, patients should receive pre-test and post-test counseling. Informed consent is recommended.

Test Methodology See individual tests.
Note: The performance characteristics of this test were validated by Transgenomic Labs. The U.S. Food and Drug Administration (FDA) has not approved this test. However, FDA approval is currently not required for clinical use of this test. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions. Transgenomic Labs is authorized under Clinical Laboratory Improvement Amendments (CLIA) to perform high-complexity testing.